FDA seeking 'aggressive' adoption of AI . The FDA announced an "aggressive timeline" to deploy artificial intelligence ...

The FDA and NIH recently announced plans to phase out animal testing requirements for some therapies. While organoid and AI ...

Jeremy Walsh, who was recently named as the FDA's first-ever AI officer, has reportedly led the discussions with OpenAI, but so far, "no contract has been signed." 'Broader trend of AI adoption in ...

The annual analysis documented approvals of 18 new personalized medicines in 2024, important regulatory milestones and establishment of the Center fo ...

Guest blog from Laura Foster, Associate Director for Technology and Innovation at techUK , as part of our ...

Lantern Pharma's Q1 2025 earnings reveal clinical progress, AI commercialization plans, and financial discipline.

The unintentional theme of today’s issue is the struggle for control over how we implement AI in the U.S. On one side, where ...

GE HealthCare (Nasdaq: GEHC) today announced the launch of its CleaRecon DL technology for enhancing CBCT imaging.